Vanguard Group Inc ownership in AKP / Anika Therapeutics, Inc.

Anika Therapeutics, Inc.

DE ˙ DB ˙ US0352551081

11,90 € 0,00 (0,00%)

2026-06-04
PREZZO DELLE AZIONI

Security	DE:AKP / Anika Therapeutics, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Anika Therapeutics, Inc. (DE:AKP). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 764,045 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-26	2026-03-26	13G/A	764,045	0	-100.00	0.00	-100.00
2024-02-13	2024-02-13	13G/A	983,768	764,045	-22.33	5.22	-22.44
2023-02-09	2023-02-09	13G/A	965,913	983,768	1.85	6.73	0.60
2022-02-09	2022-02-09	13G/A	934,282	965,913	3.39	6.69	1.83
2021-02-10	2021-02-10	13G/A	915,596	934,282	2.04	6.57	2.50
2020-02-12	2020-02-12	13G/A	879,651	915,596	4.09	6.41	3.72
2019-02-11	2019-02-11	13G/A	834,970	879,651	5.35	6.18	8.61
2018-02-12	2018-02-12	13G/A	845,044	834,970	-1.19	5.69	-1.39
2017-02-09	2017-02-09	13G		845,044		5.77

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	779,165	-1,498	-0.19	7,488	2.03	0.0001
2025-11-07	2025-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	780,663	1,190	0.15	7,338	-11.01	0.0001
2025-08-11	2025-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	779,473	2,068	0.27	8,247	-29.42	0.0001
2025-05-09	2025-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	777,405	12,135	1.59	11,684	-7.24	0.0002
2025-02-11	2024-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	765,270	-33,373	-4.18	12,596	-36.15	0.0002
2024-11-13	2024-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	798,643	8,507	1.08	19,726	-1.44	0.0004
2024-08-13	2024-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	790,136	16,434	2.12	20,014	1.84	0.0004
2024-05-10	2024-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	773,702	9,657	1.26	19,652	13.51	0.0004
2024-03-11	2023-12-31	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	764,045	-3,752	-0.49	17,313	21.04	0.0004
2024-02-14	2023-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	764,045	-3,752		17,313		0.0003
2023-12-18	2023-09-30	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	767,797	-192,909	-20.08	14,304	-42.69	0.0004
2023-11-14	2023-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	767,797	-192,909		14,304		0.0004
2023-08-14	2023-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	960,706	-21,497	-2.19	24,959	-11.52	0.0006
2023-07-14	2023-03-31	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	982,203	-1,565	-0.16	28,209	-3.13	0.0007
2023-05-15	2023-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	982,203	-1,565		28,209		0.0007
2023-02-10	2022-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	983,768	-3,600	-0.36	29,120	23.92	0.0008
2022-11-14	2022-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	987,368	12,125	1.24	23,499	7.96	0.0007
2022-08-12	2022-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	975,243	-10,252	-1.04	21,767	-12.04	0.0006
2022-05-13	2022-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	985,495	19,582	2.03	24,746	-28.50	0.0006
2022-02-14	2021-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	965,913	13,535	1.42	34,608	-14.62	0.0008
2021-11-12	2021-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	952,378	-5,323	-0.56	40,534	-2.23	0.0010
2021-08-13	2021-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	957,701	37,203	4.04	41,459	10.42	0.0010
2021-05-14	2021-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	920,498	-13,784	-1.48	37,547	-11.21	0.0010
2021-02-12	2020-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	934,282	23,246	2.55	42,286	31.15	0.0012
2020-11-16	2020-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	911,036	-2,207	-0.24	32,243	-6.43	0.0011
2020-08-14	2020-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	913,243	-10,122	-1.10	34,457	29.08	0.0012
2020-05-15	2020-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	923,365	7,769	0.85	26,694	-43.77	0.0011
2020-02-14	2019-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	915,596	-4,363	-0.47	47,474	-5.98	0.0016
2019-11-14	2019-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	919,959	3,701	0.40	50,496	35.68	0.0019
2019-08-14	2019-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	916,258	3,182	0.35	37,218	34.79	0.0014
2019-05-15	2019-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	913,076	33,425	3.80	27,611	-6.61	0.0011
2019-02-14	2018-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	879,651	18,082	2.10	29,565	-18.64	0.0013
2018-12-13	2018-09-30	13F/A-2	ANIKA THERAPEUTICS	COM	035255108	861,569	8,799	1.03	36,340	33.17	0.0014
2018-11-23	2018-09-30	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	861,569	0		36,340		0.0014
2018-11-14	2018-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	861,569	8,799		36,340
2018-08-14	2018-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	852,770	16,598	1.98	27,289	-34.36	0.0011
2018-05-15	2018-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	836,172	1,202	0.14	41,575	-7.64	0.0018
2018-02-14	2017-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	834,970	4,622	0.56	45,013	-6.53	0.0020
2017-11-14	2017-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	830,348	23,309	2.89	48,160	20.95	0.0023
2017-08-24	2017-06-30	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	807,039	15,797	2.00	39,818	15.84	0.0020
2017-08-11	2017-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	807,039	15,797		39,818
2017-05-12	2017-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	791,242	-53,802	-6.37	34,372	-16.92	0.0018
2017-02-14	2016-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	845,044	12,889	1.55	41,373	3.90	0.0023
2016-11-14	2016-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	832,155	14,931	1.83	39,819	-9.18	0.0023
2016-08-10	2016-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	817,224	75,648	10.20	43,844	32.21	0.0027
2016-05-13	2016-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	741,576	102,614	16.06	33,163	36.01	0.0021
2016-02-08	2015-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	638,962	6,941	1.10	24,382	21.20	0.0016
2015-11-12	2015-09-30	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	632,021	32,197	5.37	20,117	1.54	0.0009
2015-11-12	2015-09-30	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	632,021	32,197		20,117		0.0009
2015-11-12	2015-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	7,563,856			291,830
2015-08-13	2015-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	599,824	-62,416	-9.42	19,812	-27.33	0.0013
2015-05-15	2015-03-31	13F/A-1	ANIKA THERAPEUTICS	COM	035255108	662,240	9,391	1.44	27,264	2.51	0.0018
2015-05-14	2015-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	662,240			27,264
2015-02-12	2014-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	652,849	41,791	6.84	26,597	18.73	0.0019
2014-11-12	2014-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	611,058	63,557	11.61	22,401	-11.69	0.0017
2014-08-11	2014-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	547,501	75,752	16.06	25,366	30.83	0.0020
2014-05-13	2014-03-31	13F	ANIKA THERAPEUTICS	COM	035255108	471,749	96	0.02	19,389	7.73	0.0016
2014-02-12	2013-12-31	13F	ANIKA THERAPEUTICS	COM	035255108	471,653	61,676	15.04	17,998	83.22	0.0016
2013-11-07	2013-09-30	13F	ANIKA THERAPEUTICS	COM	035255108	409,977	-3,947	-0.95	9,823	39.59	0.0010
2013-08-13	2013-06-30	13F	ANIKA THERAPEUTICS	COM	035255108	413,924	413,924		7,037		0.0007

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.